国际标准期刊号: 2165-7092
Bin Zhu
Pancreatic adenocarcinoma, recognized for its aggressive phenotypic traits and deleterious clinical outcomes, poses a substantial obstacle in the realm of oncological research and clinical practice. Central to the comprehension and management of this devastating disease are the intricate mechanisms underlying pancreatic cancer cells. In this comprehensive exploration, we delve into the dynamic panorama of pancreatic cancer cells, elucidating their origins, molecular characteristics, signaling pathways, and therapeutic susceptibilities.